Atypical Antipsychotic class drugs

29 results
  • abilify

    (ARIPIPRAZOLE)
    Otsuka America Pharmaceutical, Inc.
    ABILIFY (aripiprazole) is indicated for the treatment of schizophrenia, acute manic and mixed episodes associated with Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and treatment of Tourette's disorder.
  • abilify asimtufii

    (Aripiprazole)
    Otsuka America Pharmaceutical, Inc
    ABILIFY ASIMTUFII is indicated for the treatment of schizophrenia in adults and for maintenance monotherapy of bipolar I disorder in adults.
  • abilify mycite

    (ARIPIPRAZOLE)
    Otsuka America Pharmaceutical, Inc.
    ABILIFY MYCITE is indicated for treating adults with schizophrenia, bipolar I disorder (including both acute and maintenance phases), and as adjunctive therapy for Major Depressive Disorder. It features an Ingestible Event Marker (IEM) sensor to track medication ingestion.
  • aripiprazole

    (Aripiprazole)
    Advagen Pharma Ltd
    Aripiprazole Oral Solution is indicated for the treatment of schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette’s disorder.
  • asenapine

    (ASENAPINE)
    Sigmapharm Laboratories, LLC
    Asenapine sublingual tablets are indicated for the adjunctive treatment of Bipolar I disorder in adults, specifically in combination with lithium or valproate.
  • clozapine

    (clozapine)
    Mylan Pharmaceuticals Inc.
    Clozapine tablets are indicated for treating treatment-resistant schizophrenia in severely ill patients not responding to standard antipsychotics. They also reduce the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder at chronic risk for suicide.
  • clozapine

    (CLOZAPINE)
    Aurobindo Pharma Limited
    Clozapine tablets are indicated for treating treatment-resistant schizophrenia in patients who inadequately respond to other antipsychotics and for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder at chronic risk for suicide.
  • fanapt

    (iloperidone)
    Vanda Pharmaceuticals Inc.
    FANAPT® is indicated for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.